EcoDrugPlus

Ensembl ID : ENSCSAVG00000000846
Gene Symbol: -
1 Cross references
187 Possible Orthologues:

Ensembl ID : ENSCSAVG00000000883
Gene Symbol: -
1 Cross references
281 Possible Orthologues:

Ensembl ID : ENSCSAVG00000001293
Gene Symbol: -
1 Cross references
477 Possible Orthologues:

Ensembl ID : ENSCSAVG00000001349
Gene Symbol: -
1 Cross references
188 Possible Orthologues:

Ensembl ID : ENSCSAVG00000002219
Gene Symbol: -
1 Cross references
229 Possible Orthologues:

Ensembl ID : ENSCSAVG00000009838
Gene Symbol: -
1 Cross references
199 Possible Orthologues:

Ensembl ID : ENSCSAVG00000009964
Gene Symbol: -
1 Cross references
665 Possible Orthologues:

Ensembl ID : ENSCSAVG00000009986
Gene Symbol: -
1 Cross references
368 Possible Orthologues:

Ensembl ID : ENSCSAVG00000010010
Gene Symbol: -
1 Cross references
222 Possible Orthologues:

Ensembl ID : ENSCSAVG00000010289
Gene Symbol: -
1 Cross references
207 Possible Orthologues:

Ensembl ID : ENSCSAVG00000010495
Gene Symbol: -
1 Cross references
1281 Possible Orthologues:

Ensembl ID : ENSCSAVG00000010515
Gene Symbol: -
1 Cross references
461 Possible Orthologues:

Select Keywords:


PREMIER has received funding from the Innovative Medicines Initiative 2 Joint Undertaking (JU) under grant agreement No 875508. The JU receives support from the EU’s Horizon 2020 research and innovation programme and the European Federation of Pharmaceutical Industries and Associations (EFPIA). The views reflect only the authors’ perspective and the JU is not responsible for any use that may be made of the information this manuscript contains. Elements of the website have been developed under projects PREMIER and the Biocenter Finland Drug Discovery and Chemical Biology network. CSC-IT is thanked for providing computational resources. Content of the website is provided without guarantee for correctness. Data has been collected and integrated from multiple public sources, for the largest: FDA, HUGO Gene Nomenclature Committee, ChEMBL, IUPHAR/BPS guide to pharmacology, Reactome, UniProt, and Ensembl. Credit is given to Ensembl for collecting species images (provided under public domain licences such as Wikimedia and NHGRI).

PREMIER has received funding from the Innovative Medicines Initiative 2 Joint Undertaking (JU) under grant agreement No 875508. The JU receives support from the EU’s Horizon 2020 research and innovation programme and the European Federation of Pharmaceutical Industries and Associations (EFPIA). The views reflect only the authors’ perspective and the JU is not responsible for any use that may be made of the information this manuscript contains.

Elements of the website have been developed under projects PREMIER and the Biocenter Finland Drug Discovery and Chemical Biology network. CSC-IT is thanked for providing computational resources. Content of the website is provided without guarantee for correctness. Data has been collected and integrated from multiple public sources, for the largest: FDA, HUGO Gene Nomenclature Committee, ChEMBL, IUPHAR/BPS guide to pharmacology, Reactome, UniProt, and Ensembl. Credit is given to Ensembl for collecting species images (provided under public domain licences such as Wikimedia and NHGRI).